We are Sorry, This Page doesn't Exist
Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2018
Significant progress with RPL554 as potential treatment for COPD and CF Recently initiated important Phase 2 trial as add-on to dual bronchodilator therapy for COPD maintenance treatm.....»»
Eiger positive data opens HDV triple combo opportunity, says Piper Jaffray
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Selecta SEL-212 data "very competitive to Krystexxa mono/combo therapy, says Stifel
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Virtual reality could revolutionize mental-health treatments, including ketamine therapy, for conditions like depression and anxiety
Virtual reality could revolutionize mental-health treatments, including ketamine therapy, for conditions like depression and anxiety.....»»
Five things you need to know today, and it"s gonna be ... a busy May
Good morning, Cincinnati! Here are the top business news stories you need to know from yesterday. Kroger has committed to invest $84 million – almost triple its usual amount this year – to open a store and remodel 15 others in its Cincinnati/Dayton.....»»
A hacker got 6 years in prison for stealing therapy notes and blackmailing patients
Aleksanteri Kivimäki was found guilty of hacking a therapy company and trying to extort its patients. He was sentenced to over six years in prison. A stock image shows a therapist making notes ahead of a session with a p.....»»
Johnson & Johnson-Partnered Addex Therapeutics" Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
Latest Phase 2 epilepsy study findings on ADX71149 adjunctive therapy for focal onset seizures. Partnered with Janssen, Addex Therapeutics evaluates treatment efficacy in patients with suboptimal response to standard care. read more.....»»
Pfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose
Pfizer's huge facility in Sanford produces its first FDA-approved gene therapy, which runs $3.5 million a dose......»»
How big is St. Louis County’s largest city? Almost triple the size of 100 others
How big is St. Louis County’s largest city? Almost triple the size of 100 others.....»»
From Gen Alpha to boomers, we asked 6 therapists what each generation is talking about in therapy
In 2022, almost a quarter of U.....»»
Walgreens to open cell and gene therapy pharmacy center in Pittsburgh
It's part of the growing market share of specialty drugs......»»
Columbia defense contractor aims to triple in size after investment
The Columbia company's growth plans are fueled by a big investment from a D.C. private equity firm......»»
Doctors and patients loathe ‘step therapy’ rules, but insurers say they’re necessary. An Illinois bill would prohibit the practice.
Doctors and advocat.....»»
San Francisco"s Perplexity AI in talks to double funding, triple valuation
San Francisco search startup Perplexity AI has raised $165 million over three rounds since early 2023, and is reportedly in talks to raise another, even bigger, round......»»
Skyline Construction to relocate downtown Chicago office this fall
Skyline Construction will nearly triple its Chicago office space when it relocates to Wacker Drive......»»
FDA Approves Novartis" Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
Discover Novartis' FDA approval for Lutathera in pediatric patients with GEP-NETs, marking a pivotal milestone in treating this rare cancer. Explore its efficacy in combating SSTR+ tumors, backed by robust trial data. read more.....»»
Céline Dion says she goes to therapy 5 days a week and trains "like an athlete" as part of her treatment plan
"I hope that we'll find a miracle, a way to cure it wit.....»»
Cell therapy firm acquires RTP manufacturing facility
A company that's backed by a venture capital firm in Raleigh is expanding its local footprint......»»